Plewa, S.; Poplawska-Domaszewicz, K.; Florczak-Wyspianska, J.; Klupczynska-Gabryszak, A.; Sokol, B.; Miltyk, W.; Jankowski, R.; Kozubski, W.; Kokot, Z.J.; Matysiak, J.
The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients. Pharmaceuticals 2021, 14, 935.
https://doi.org/10.3390/ph14090935
AMA Style
Plewa S, Poplawska-Domaszewicz K, Florczak-Wyspianska J, Klupczynska-Gabryszak A, Sokol B, Miltyk W, Jankowski R, Kozubski W, Kokot ZJ, Matysiak J.
The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients. Pharmaceuticals. 2021; 14(9):935.
https://doi.org/10.3390/ph14090935
Chicago/Turabian Style
Plewa, Szymon, Karolina Poplawska-Domaszewicz, Jolanta Florczak-Wyspianska, Agnieszka Klupczynska-Gabryszak, Bartosz Sokol, Wojciech Miltyk, Roman Jankowski, Wojciech Kozubski, Zenon J. Kokot, and Jan Matysiak.
2021. "The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients" Pharmaceuticals 14, no. 9: 935.
https://doi.org/10.3390/ph14090935
APA Style
Plewa, S., Poplawska-Domaszewicz, K., Florczak-Wyspianska, J., Klupczynska-Gabryszak, A., Sokol, B., Miltyk, W., Jankowski, R., Kozubski, W., Kokot, Z. J., & Matysiak, J.
(2021). The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients. Pharmaceuticals, 14(9), 935.
https://doi.org/10.3390/ph14090935
